|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents (at cost $1,345,734,884 and $651,873,522, respectively) (Notes 2 and 5) | ||||||||||||||||||||
| Equity in trading accounts: | ||||||||||||||||||||
| Cash and cash equivalents (at cost $832,784,819 and $241,747,983, respectively) | ||||||||||||||||||||
| Unrealized gain (loss) on open commodity futures contracts | ||||||||||||||||||||
| Unrealized gain (loss) on open OTC commodity swap contracts | ||||||||||||||||||||
| Unrealized gain (loss) on open swap contracts | ||||||||||||||||||||
| Due from Broker | ||||||||||||||||||||
| Receivable for shares sold | ||||||||||||||||||||
| Dividends receivable | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Prepaid insurance | ||||||||||||||||||||
| ETF Transaction Fees Receivable | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Partners' Capital | ||||||||||||||||||||
| Payable due to Broker | ||||||||||||||||||||
| Payable for shares redeemed | ||||||||||||||||||||
| General Partner management fees payable (Note 3) | ||||||||||||||||||||
| Professional fees payable | ||||||||||||||||||||
| Due to custody | ||||||||||||||||||||
| Brokerage commissions payable | ||||||||||||||||||||
| Directors' fees payable | ||||||||||||||||||||
| License fees payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Partners' Capital | ||||||||||||||||||||
| General Partners | ||||||||||||||||||||
| Limited Partners | ||||||||||||||||||||
| Total Partners' Capital | ||||||||||||||||||||
| Total Liabilities and Partners' Capital | ||||||||||||||||||||
| Limited Partners' shares outstanding | ||||||||||||||||||||
| Net asset value per share | ||||||||||||||||||||
| Market value per share | ||||||||||||||||||||
Loading...
